Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

PAVmed (PAVM) Cash from Investing Activities (2022 - 2025)

Historic Cash from Investing Activities for PAVmed (PAVM) over the last 4 years, with Q3 2025 value amounting to -$3000.0.

  • PAVmed's Cash from Investing Activities changed N/A to -$3000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$21000.0, marking a year-over-year change of. This contributed to the annual value of -$16.2 million for FY2024, which is 223509.23% down from last year.
  • As of Q3 2025, PAVmed's Cash from Investing Activities stood at -$3000.0.
  • PAVmed's 5-year Cash from Investing Activities high stood at $974000.0 for Q1 2023, and its period low was -$2.6 million during Q2 2022.
  • Over the past 4 years, PAVmed's median Cash from Investing Activities value was -$16500.0 (recorded in 2023), while the average stood at -$289142.9.
  • Per our database at Business Quant, PAVmed's Cash from Investing Activities surged by 26968.64% in 2023 and then tumbled by 16666.67% in 2025.
  • PAVmed's Cash from Investing Activities (Quarter) stood at -$298000.0 in 2022, then skyrocketed by 38.59% to -$183000.0 in 2023, then skyrocketed by 97.81% to -$4000.0 in 2024, then increased by 25.0% to -$3000.0 in 2025.
  • Its Cash from Investing Activities was -$3000.0 in Q3 2025, compared to -$8000.0 in Q2 2025 and -$6000.0 in Q1 2025.